The Palliative Management of Refractory Cirrhotic Ascites Using the PleurX^© Catheter

Table 3

Relative risks (RR) for variables related to catheter-associated SBP and adverse events.

Variable	Catheter-associated SBP		Adverse events
	RR	95% CI	RR	95% CI
Age ≥ 65 years	1.4	0.54, 3.42	0.9	0.49, 1.83
Male gender	0.9	0.33, 2.14	1.2	0.62, 2.40
Cardiovascular disease	1.8	0.70, 4.36	1.4	0.74, 2.52
Chronic kidney disease	1.0	0.36, 2.90	1.2	0.54, 2.57
ECOG ≥ 3	1.6	0.27, 9.33	1.2	0.41, 3.24
Hyponatremia	2.0	0.65, 6.26	1.2	0.62, 2.34
Ascitic protein > 10 g/L	1.8	0.31, 10.55	1.3	0.47, 3.63
MELD≥ 15	0.3	0.09, 0.84	0.6	0.34, 1.14
Child-Pugh class B	6.5	0.96, 43.72	2.0	0.86, 4.57

Adverse events included catheter obstruction or displacement, infections, prerenal azotemia, hematoma, or ascites outflow around the catheter site.
SBP, spontaneous bacterial peritonitis.
CI, confidence interval.
Eastern cooperative oncology group performance status score.
Serum sodium < 135 mmol/L.
Model for end-stage liver disease score.
p value ≤ 0.05.